These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9123886)

  • 1. [Mechanism of HIV replication].
    Adachi A; Yamamoto Y; Sone S
    Uirusu; 1996 Dec; 46(2):145-54. PubMed ID: 9123886
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of expression of human immunodeficiency virus.
    Pavlakis GN; Felber BK
    New Biol; 1990 Jan; 2(1):20-31. PubMed ID: 2078551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins.
    Ulich C; Harrich D; Estes P; Gaynor RB
    J Virol; 1996 Jul; 70(7):4871-6. PubMed ID: 8676525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility of Tat and Rev transactivators in the primate lentiviruses.
    Sakai H; Sakuragi J; Sakuragi S; Kawamura M; Adachi A
    Arch Virol; 1993; 129(1-4):1-10. PubMed ID: 8385908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulatory mechanism of HIV gene expression].
    Hatanaka M
    Nihon Rinsho; 1993 Sep; 51 Suppl():43-57. PubMed ID: 8271415
    [No Abstract]   [Full Text] [Related]  

  • 6. Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells.
    Duan L; Oakes JW; Ferraro A; Bagasra O; Pomerantz RJ
    Virology; 1994 Mar; 199(2):474-8. PubMed ID: 8122376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tat and Rev: positive modulators of human immunodeficiency virus gene expression.
    Rosen CA
    Gene Expr; 1991 May; 1(2):85-90. PubMed ID: 1820213
    [No Abstract]   [Full Text] [Related]  

  • 8. Virus-host interactions: role of HIV proteins Vif, Tat, and Rev.
    Strebel K
    AIDS; 2003; 17 Suppl 4():S25-34. PubMed ID: 15080177
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlling elements in replication of the human immunodeficiency virus type 1.
    Li X; Quan Y; Wainberg MA
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):443-54. PubMed ID: 9193800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [RNA ligands for HIV proteins].
    Iwai S
    Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1430-7. PubMed ID: 7568944
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells.
    Harrison GS; Maxwell F; Long CJ; Rosen CA; Glode LM; Maxwell IH
    Hum Gene Ther; 1991; 2(1):53-60. PubMed ID: 1863640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 by a double transdominant fusion gene.
    Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
    Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tat and Rev: positive regulators of HIV gene expression.
    Rosen CA; Pavlakis GN
    AIDS; 1990 Jun; 4(6):499-509. PubMed ID: 2201316
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA molecule.
    Lisziewicz J; Zeng G; Gratas C; Weinstein JN; Lori F
    Hum Gene Ther; 2000 Apr; 11(6):807-15. PubMed ID: 10779158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transduction of cell lines and primary cells by FIV-packaged HIV vectors.
    Morris KV; Gilbert J; Wong-Staal F; Gasmi M; Looney DJ
    Mol Ther; 2004 Jul; 10(1):181-90. PubMed ID: 15272479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.
    Lassen KG; Ramyar KX; Bailey JR; Zhou Y; Siliciano RF
    PLoS Pathog; 2006 Jul; 2(7):e68. PubMed ID: 16839202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-sequence-mediated gene regulation in HIV-1.
    Cullen BR
    Infect Agents Dis; 1994; 3(2-3):68-76. PubMed ID: 7812657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tat's seductive side.
    Stevenson M
    Nat Med; 2003 Feb; 9(2):163-4. PubMed ID: 12563332
    [No Abstract]   [Full Text] [Related]  

  • 19. [Targets and possible therapeutic interventions for HIV carriers].
    Kageyama S; Kurimura T
    Nihon Rinsho; 1993 Sep; 51 Suppl():351-6. PubMed ID: 8271402
    [No Abstract]   [Full Text] [Related]  

  • 20. Robust growth of human immunodeficiency virus type 1 (HIV-1).
    Kim H; Yin J
    Biophys J; 2005 Oct; 89(4):2210-21. PubMed ID: 16055539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.